Keybank National Association OH Trims Position in Kenvue Inc. $KVUE

Keybank National Association OH lowered its position in Kenvue Inc. (NYSE:KVUE) by 5.2% in the third quarter, HoldingsChannel reports. The firm owned 4,628,939 shares of the company’s stock after selling 256,023 shares during the period. Keybank National Association OH’s holdings in Kenvue were worth $75,128,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of KVUE. Berman McAleer LLC purchased a new position in Kenvue during the third quarter worth about $195,000. National Pension Service raised its position in shares of Kenvue by 1.0% during the 3rd quarter. National Pension Service now owns 2,804,961 shares of the company’s stock valued at $45,525,000 after buying an additional 27,914 shares during the period. AlphaQuest LLC raised its position in shares of Kenvue by 110.8% during the 3rd quarter. AlphaQuest LLC now owns 25,472 shares of the company’s stock valued at $413,000 after buying an additional 13,386 shares during the period. Golden State Wealth Management LLC lifted its holdings in Kenvue by 150.1% in the third quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock valued at $32,000 after acquiring an additional 1,190 shares during the last quarter. Finally, Great Lakes Advisors LLC grew its position in Kenvue by 42.2% in the third quarter. Great Lakes Advisors LLC now owns 289,626 shares of the company’s stock worth $4,701,000 after acquiring an additional 85,901 shares during the period. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Kenvue Stock Up 1.2%

Shares of KVUE opened at $17.41 on Friday. The company’s 50-day simple moving average is $17.16 and its 200-day simple moving average is $18.04. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 0.98. Kenvue Inc. has a 1 year low of $14.02 and a 1 year high of $25.17. The stock has a market capitalization of $33.36 billion, a PE ratio of 23.21 and a beta of 0.60.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Monday, November 3rd. The company reported $0.28 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.01. The firm had revenue of $3.76 billion during the quarter, compared to analysts’ expectations of $3.83 billion. Kenvue had a net margin of 9.55% and a return on equity of 20.02%. The business’s quarterly revenue was down 3.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.28 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 25th. Stockholders of record on Wednesday, February 11th will be given a dividend of $0.2075 per share. The ex-dividend date of this dividend is Wednesday, February 11th. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.8%. Kenvue’s dividend payout ratio is currently 110.67%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on KVUE shares. Barclays upped their price target on Kenvue from $17.00 to $18.00 and gave the company an “equal weight” rating in a research note on Monday, November 10th. UBS Group decreased their target price on shares of Kenvue from $23.00 to $17.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 8th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Kenvue in a research note on Friday, January 9th. Johnson Rice reissued a “neutral” rating on shares of Kenvue in a research note on Tuesday, October 28th. Finally, Canaccord Genuity Group restated a “hold” rating and issued a $15.00 price objective (down from $26.00) on shares of Kenvue in a report on Wednesday, October 29th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and thirteen have issued a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $19.90.

Insider Activity

In related news, Director Jeffrey C. Smith bought 3,200,000 shares of the firm’s stock in a transaction that occurred on Friday, December 12th. The stock was purchased at an average cost of $17.37 per share, for a total transaction of $55,584,000.00. Following the completion of the acquisition, the director owned 27,307,632 shares in the company, valued at approximately $474,333,567.84. This trade represents a 13.27% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.68% of the company’s stock.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.